Buprenorphine Cost Effectiveness
Buprenorphine Cost Effectiveness
Buprenorphine Cost Effectiveness
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Conclusions<br />
• Office-based buprenorphine for clinically<br />
stable patients is cost-effective compared to<br />
no treatment using accepted thresholds for<br />
medical treatment in the US<br />
• Price reductions have a small effect on costeffectiveness<br />
findings<br />
– Not appropriate to refuse treatment coverage until<br />
generic buprenorphine/naloxone is available on<br />
the basis of cost-effectiveness<br />
• Lack of certainty about quality-of-life weights<br />
reduces robustness of findings<br />
– Further research about quality of life on and off<br />
buprenorphine is necessary<br />
18
Change language